BioLoomics is a biotechnology company that leverages directed evolution and advanced technologies like synthetic biology, AI, and robotics to develop innovative antibody-drug conjugates (ADCs) for safer and more effective cancer therapies. Founded in 2019, the company has transitioned from a university lab to a cutting-edge facility, focusing on creating next-generation complex antibodies that address unmet medical needs. With a strong team of experts and a robust therapeutic pipeline, BioLoomics aims to revolutionize cancer treatment and improve patient outcomes.

Boulder, CO, USA

BioLoomics

Innovation Endeavors invests in visionary founders, transformational technology and emergent ecosystems for a new world.

Innovation Endeavors

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Innovation Endeavors Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Innovation Endeavors network as they come up.

You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Innovation Endeavors company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Investing in visionary founders, transformational technology and emergent ecosystems for a new world.